Zami Aberman

2008

In 2008, Zami Aberman earned a total compensation of $765.9K as Chief Executive Officer at Pluristem Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$41,287
Salary$312,565
Stock Awards$412,051
Total$765,903

Aberman received $412.1K in stock awards, accounting for 54% of the total pay in 2008.

Aberman also received $41.3K in non-equity incentive plan and $312.6K in salary.

Rankings

In 2008, Zami Aberman's compensation ranked 5,198th out of 9,135 executives tracked by ExecPay. In other words, Aberman earned more than 43.1% of executives.

ClassificationRankingPercentile
All
5,198
out of 9,135
43rd
Division
Manufacturing
1,889
out of 3,436
45th
Major group
Chemicals And Allied Products
377
out of 815
54th
Industry group
Drugs
234
out of 597
61st
Industry
Biological Products, Except Diagnostic Substances
39
out of 118
67th
Source: SEC filing on November 23, 2009.

Aberman's colleagues

We found one more compensation record of an executive who worked with Zami Aberman at Pluristem Therapeutics in 2008.

2008

Yaky Yanay

Pluristem Therapeutics

Chief Financial Officer

News

You may also like